Powley Mark W, Walker Vernon E, Li Yutai, Upton Patricia B, Swenberg James A
Environmental Sciences and Engineering, University of North Carolina School of Public Health, Chapel Hill, NC 27599-7431, USA.
Chem Biol Interact. 2007 Mar 20;166(1-3):182-90. doi: 10.1016/j.cbi.2007.02.001. Epub 2007 Feb 9.
1,2:3,4-Diepoxybutane is hypothesized to be the main intermediate involved in mutagenicity following exposure to low levels of 1,3-butadiene (BD) in mice, while metabolites of 3-butene-1,2-diol (BD-diol) are thought to become involved in both rats and mice at higher exposures. BD-diol is biotransformed to hydroxymethylvinyl ketone (HMVK), a potentially mutagenic metabolite, and 3,4-epoxy-1,2-butanediol (EB-diol), a known mutagen. To determine the relative importance of HMVK and EB-diol in BD-diol associated mutagenesis, we have examined the dosimetry of a HMVK derived DNA adduct, as well as EB-diol derived DNA and hemoglobin adducts, in rodents exposed to BD-diol. We previously demonstrated similarities in the shapes of the dose-response curves for EB-diol derived DNA adducts, hemoglobin adducts, and Hprt mutant frequencies in BD-diol exposed rodents, indicating that EB-diol was involved in the mutagenic response associated with BD-diol exposure. To examine the role of HMVK in BD-diol mutagenicity, a method to quantify the alpha-regioisomer of HMVK derived 1,N(2)-propanodeoxyguanosine (alpha-HMVK-dGuo) was developed. The method involved enzymatic hydrolysis of DNA, HPLC purification, and adduct measurement by liquid chromatography - tandem mass spectrometry. Intra- and inter-experimental variabilities were determined to be 2.3-18.2 and 4.1%, respectively. The limit of detection was approximately 5 fmol of analyte standard injected onto the column or 5 fmol/200 microg DNA. The method was used to analyze liver DNA from control female F344 rats and female F344 rats exposed to 36 ppm BD-diol. In addition, liver samples from female Sprague-Dawley rats exposed to 1000 ppm BD were analyzed. alpha-HMVK-dGuo was not detected in any of the samples analyzed. Several possible explanations exist for the negative results including the possibility that alpha-HMVK-dGuo may be a minor adduct or may be efficiently repaired. Alternatively, HMVK itself may be readily detoxified by glutathione (GSH) conjugation. While experiments must be conducted to understand the exact mechanism(s), these results, in addition to published EB-diol derived adduct dosimetry and existing HMVK derived mercapturic acid data, suggest that EB-diol is primarily responsible for BD-diol induced mutagenicity in rodents.
据推测,1,2:3,4 - 二环氧丁烷是小鼠接触低水平1,3 - 丁二烯(BD)后致突变性的主要中间体,而在大鼠和小鼠接触较高剂量时,3 - 丁烯 - 1,2 - 二醇(BD - 二醇)的代谢产物被认为参与其中。BD - 二醇可生物转化为潜在致突变性代谢产物羟甲基乙烯基酮(HMVK)和已知的诱变剂3,4 - 环氧 - 1,2 - 丁二醇(EB - 二醇)。为了确定HMVK和EB - 二醇在BD - 二醇相关诱变中的相对重要性,我们检测了接触BD - 二醇的啮齿动物中HMVK衍生的DNA加合物以及EB - 二醇衍生的DNA和血红蛋白加合物的剂量学。我们之前证明,在接触BD - 二醇的啮齿动物中,EB - 二醇衍生的DNA加合物、血红蛋白加合物和Hprt突变频率的剂量 - 反应曲线形状相似,这表明EB - 二醇参与了与BD - 二醇接触相关的诱变反应。为了研究HMVK在BD - 二醇诱变性中的作用,我们开发了一种定量HMVK衍生的1,N(2) - 丙烷脱氧鸟苷(α - HMVK - dGuo)α - 区域异构体的方法。该方法包括DNA的酶促水解、HPLC纯化以及通过液相色谱 - 串联质谱法测量加合物。实验内和实验间的变异性分别确定为2.3 - 18.2%和4.1%。检测限约为注入柱中的5 fmol分析物标准品或5 fmol/200 μg DNA。该方法用于分析对照雌性F344大鼠和接触36 ppm BD - 二醇的雌性F344大鼠的肝脏DNA。此外,还分析了接触1000 ppm BD的雌性Sprague - Dawley大鼠的肝脏样本。在所分析的任何样本中均未检测到α - HMVK - dGuo。对于这些阴性结果存在几种可能的解释,包括α - HMVK - dGuo可能是一种次要加合物或可能被有效修复的可能性。或者,HMVK本身可能很容易通过谷胱甘肽(GSH)结合而解毒。虽然必须进行实验以了解确切机制,但这些结果,除了已发表的EB - 二醇衍生加合物剂量学和现有的HMVK衍生巯基尿酸数据外,表明EB - 二醇是啮齿动物中BD - 二醇诱导的诱变性的主要原因。